2D-Health have developed and launched a questionnaire to gain an understanding of the public’s view on the use of nanomaterials as therapeutic agents, specifically for cancer immunotherapy.
The initiative also aims to inform the public on how combining nanomaterials with cancer medicines could help target cancers and reduce the possible side effects of current cancer medicines.
The data collected from the questionnaire will help to guide future research into the development of these new cancer therapeutics.
This survey was developed with support from Vocal, bringing people and health research together.
The survey is still open so click here to take part.